RPE scores were recorded at peak exercise.
Arterial blood was sampled at rest and at peak exercise.
Bortezomib-treated D307H mice had lower CPVT prevalence and less premature ventricular beats during peak exercise.
Only the non-obese women showed a decrease in PaCO2 rest to peak exercise (−5 ± 3 mmHg).
Main Outcome Measures: Cardiopulmonary, hemodynamic, and physical performance parameters were assessed at peak exercise and at the lactate threshold.
Patients with chronic kidney failure (CKF) experience impaired functional cardiovascular reserve with reduced oxygen consumption at peak exercise (Vo2peak).
Exertion at peak exercise (% predicted HRmax) and hemodynamic responses were compared between conditions using paired sample t tests.
This study was designed to determine whether administration of atropine at peak exercise would maintain a higher HR longer after exercise, thereby facilitating acquisition of images.
VPCs were absent at rest in 21 of 33 studies, subsequently appearing at peak exercise in 4 studies and during recovery in 2 studies.
There was no significant difference in peak exercise parameters between the 2 groups according to median FBG or median HbA1c levels.
